Copyright © 2002 by the European Society of Cardiology.
Editorials
Nothing is lower than 0, and 3 is closer to 0 than to 5medicine is not arithmetic
Columbus Hospital and San Raffaele Hospital, Milan, Italy
References
- Holmes DR Jr., Berger PB. Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets: what's behind this new lexicon and what does it add? Circulation. 2001;104:627629
[Free Full Text] - Brener SJ, Ellis SG, Schneider J, Topol EJ. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J. 2002;23:869876
[Abstract/Free Full Text] - Oh JK, Shub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985;109:12251231[CrossRef][Web of Science][Medline]
- Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 1991;17:621626[Abstract]
- Cutlip D, Chauhan M, Lasorda D. Influence of postprocedural myocardial infarction on late clinical outcome in the Stent Anti-Thrombotic Regimen Study (STARS) (abstr.). Circulation. 1997;96:I31
- Hodakowski GT, Craver JM, Jones EL, King SB 3rd, Guyton RA. Clinical significance of perioperative Q-wave myocardial infarction: the Emory Angioplasty versus Surgery Trial. J Thorac Cardiovasc Surg. 1996;112:14471453
[Abstract/Free Full Text] - N Engl J Med. 1994;330:956961
[Abstract/Free Full Text] - Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 1996;131:10971105[CrossRef][Web of Science][Medline]
- Abdelmeguid AE, Topol EJ. The myth of the myocardial infarctlet during percutaneous coronary revascularization procedures. Circulation. 1996;94:33693375
[Free Full Text] - Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinaseMB fraction after percutaneous coronary interventions. Circulation. 1996;94:15281536
[Abstract/Free Full Text] - Califf RM, Abdelmeguid AE, Kuntz RE. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241251
[Abstract/Free Full Text] - Tardiff BE, Califf RM, Tcheng JE. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol. 1999;33:8896
[Abstract/Free Full Text] - Simoons ML, van den Brand M, Lincoff M. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J. 1999;20:11121119
[Abstract/Free Full Text] - Lancet. 1998;352:8792[Web of Science][Medline]
- Topol EJ, Mark DB, Lincoff AM. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet. 1999;354:20192024[CrossRef][Web of Science][Medline]
- Saucedo JF, Mehran R, Dangas G. Long-term clinical events following creatine kinasemyocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol. 2000;35:11341141
[Abstract/Free Full Text] - Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001;104:642647
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
J. P. A. Ioannidis, E. Karvouni, and D. G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
